CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online 2015 December 24 DOI: https://doi.org/10.3350/cmh.2015.21.4.358

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clinical and Molecular Hepatology. 2015;21(4):358

Link1 Link2 Link3

P0831 : Safety and efficacy of Sofosbuvir-based treatment regimens for chronic hepatitis C virus infection: A “Real-Life”, single-center experience in 117 patients

M.H. Wehmeyer, C. Eißing, S. Jordan, A.W. Lohse, J. Schulze zur Wiesch, S. Lüth

Journal of Hepatology. 2015;62:S649

Link1 Link2

Sa1392: EFFICACY AND SAFETY OF PAN-GENOTYPIC SOFOSBUVIR AND VELPATASVIR IN PATIENTS WITH CHRONIC HEPATITIS C AND HIV CO-INFECTION ON DOLUTEGRAVIR BASED ANTI-RETROVIRAL THERAPY

Arka De, Joshy Antony, Swati Charak, Rajwant Kaur, Talwinder Kaur, Sahaj Rathi, Nipun Verma, Madhumita Premkumar, Sunil Taneja, Ajay Duseja, Virendra Singh

Gastroenterology. 2022;162(7):S-1153

Link1 Link2

Efficacy and safety of sofosbuvir-based therapy for the treatment of chronic hepatitis C in treatment-naïve and treatment-experienced patients

Xi Liu, Yawen Wang, Guanjun Zhang, Na Li, Qianqian Zhu, Hongyun Chang, Qunying Han, Yi Lv, Zhengwen Liu

International Journal of Antimicrobial Agents. 2014;44(2):145-151

Link1 Link2

THU-113-Comparison between safety and efficacy of two treatment regimens for pediatric patients with chronic hepatitis C virus: Sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimen

Mohamed Ahmed, Abdelfattah Hanno, Soraya Hamouda, Manal Abdelgawad, Hossam Abouelkhier

Journal of Hepatology. 2019;70(1):e208

Link1 Link2

Tu1500 – Single Center Experience with Sofosbuvir/Velpatasvir/Voxilaprevir (VOSEVI) Based Therapy for Chronic Hepatitis C Infection

Patrick Brown, Zachary Demertzis, Syed-Mohammed Jafri

Gastroenterology. 2019;156(6):S-1344

Link1 Link2

Efficacy and safety of sofosbuvir-based, interferon-free therapy

A. A. Shahin, H. S. Zayed, M. Said, S. A. Amer

Zeitschrift für Rheumatologie. 2017;77(7):621-628

Link1 Link2

Link3

Efficacy and safety of sofosbuvir-based therapy for chronic hepatitis C infection in “real-life” cohort

Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandaniya, Mrunal Shah, Vishwa Bhayani

Indian Journal of Gastroenterology. 2016;35(6):459-464

Link1

Link2 Link3

Real Life Experience of Sofosbuvir Based Therapy for Chronic Hepatitis C Patients From North East India

K.S. Prasanna, Kamal Chetri, Mukesh Agarwala, Partha Roy, Arvind Kelkar

Journal of Clinical and Experimental Hepatology. 2016;6:S9

Link1 Link2

P148: Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Journal of Viral Hepatitis. 2015;22:93-93

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.